Related Experiment Videos
[Hyperlipidemia in the elderly]
1Department of Clinical Laboratory Medicine, Jichi Medical School.
Insights
High cholesterol (hypercholesterolemia) significantly increases coronary heart disease and stroke risk in the elderly. Statins effectively reduce these risks, with lifestyle changes as a primary prevention strategy.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Neurology
Context:
- Hypercholesterolemia is a significant risk factor for coronary heart disease (CHD) and ischemic stroke, particularly in the elderly population.
- Existing research indicates a strong positive association between cholesterol levels and these cardiovascular and cerebrovascular events.
Purpose:
- To review the role of cholesterol management in preventing cardiovascular and cerebrovascular diseases in older adults.
- To evaluate the efficacy of lipid-lowering therapies and lifestyle modifications for primary and secondary prevention in the elderly.
Summary:
- Large-scale studies demonstrate that HMG-CoA reductase inhibitors (statins) significantly reduce major coronary events and ischemic strokes in the elderly, mirroring benefits seen in younger populations.
- Therapeutic lifestyle changes are recommended as the first line of therapy for primary prevention.
- Pharmacological intervention with LDL-lowering drugs is considered for elderly individuals with established CHD, multiple risk factors, or advanced atherosclerosis.
- The established roles of triglycerides and HDL-cholesterol in atherosclerotic diseases among the elderly are also highlighted.
Impact:
- Provides evidence-based recommendations for managing hypercholesterolemia in the elderly to reduce cardiovascular and cerebrovascular event rates.
- Supports the use of statins and lifestyle interventions for preventing major adverse events in older adults.
- Informs clinical practice regarding lipid management strategies tailored to the specific needs and risks of the geriatric population.
Abstract:
Many studies show hypercholesterolemia is an even stronger risk factor for coronary heart disease(CHD) in the elderly, and most studies evaluated ischemic strokes separately show a positive association with cholesterol levels. Large prevention studies show HMG-CoA reductase inhibitors significantly decreased major coronary events in the elderly similar to that observed in the younger people, and were also effective in preventing ischemic stroke. For primary prevention, therapeutic life-style change is the first line of therapy for the elderly. However, LDL-lowering drugs can be considered when they are at established CHD, higher risk because of multiple risk factors, or advanced subclinical atherosclerosis. The association of triglycerides level or HDL-cholesterol level and atherosclerotic diseases has been well defined in the elderly.